Tag: Featured | Fav Store news

Pfizer and BioNTech publish data from two laboratory studies on COVID-19 vaccine-induced antibodies ability to neutralize SARS-CoV-2 Omicron variant

January 24, 2022todi0

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the publication of new results from two laboratory studies demonstrating that three doses of the Pfizer-BioNTech COVID-19 Vaccine (BNT162b2) elicited antibodies that neutralize the Omicron variant (B.1.1.529). Data published in the peer-reviewed journal Science, includes readouts of sera data from 51 vaccinated individuals that […]

SMi Group’s 13th Annual Conference: RNA Therapeutics 2022

January 24, 2022todi0

9 – 10 February 2022, Virtual Conference.The RNA therapeutics industry has grown at an exponential rate in recent years, with an increased spotlight following the industry’s leading role in developing vaccines against COVID-19 in response to the global pandemic. This year’s conference will reflect on how the industry has adapted and played a pivotal role […]

The cellular response that protects pigs from COVID-19

January 21, 2022todi0

Iowa State University scientists may have uncovered an important clue that sheds light on why pigs don’t get sick when exposed to the coronavirus. Studies since the start of the pandemic have noted that pigs can be infected by the virus if exposed to high doses, but the infection is self-limited and pigs don’t show […]

An estimated 1.2 million people died in 2019 from antibiotic-resistant bacterial infections

January 20, 2022todi0

More than 1.2 million people – and potentially millions more – died in 2019 as a direct result of antibiotic-resistant bacterial infections, according to the most comprehensive estimate to date of the global impact of antimicrobial resistance (AMR). The analysis of 204 countries and territories, published in The Lancet, reveals that AMR is now a […]

Exscientia and Sanofi establish strategic research collaboration to develop AI-driven pipeline of precision-engineered medicines

January 20, 2022todi0

Sanofi and Exscientia announced a groundbreaking research collaboration and license agreement to develop up to 15 novel small molecule candidates across oncology and immunology, leveraging Exscientia’s end-to-end AI-driven platform utilizing actual patient samples. The companies have been working together since 2016 and in 2019, Sanofi in-licensed Exscientia’s novel bispecific small molecule candidate capable of targeting […]

Placebo effect accounts for more than two-thirds of COVID-19 vaccine adverse events

January 19, 2022todi0

The placebo effect is the well-known phenomenon of a person’s physical or mental health improving after taking a treatment with no pharmacological therapeutic benefit – a sugar pill, or a syringe full of saline, for example. While the exact biological, psychological and genetic underpinnings of the placebo effect are not well understood, some theories point […]

Pfizer shares in vitro efficacy of novel COVID-19 oral treatment against omicron variant

January 18, 2022todi0

Pfizer Inc. (NYSE: PFE) today shared results from multiple studies demonstrating that the in vitro efficacy of nirmatrelvir, the active main protease (Mpro) inhibitor of PAXLOVID™ (nirmatrelvir [PF-07321332] tablets and ritonavir tablets), is maintained against the SARS-CoV-2 variant Omicron. Taken together, these in vitro studies suggest that PAXLOVID has the potential to maintain plasma concentrations […]

SMi’s 5th Annual 3D Cell Culture Conference

January 18, 2022todi0

9 – 10 February 2022, Virtual Conference: Online Access Only.3D Cell Culture is gaining momentum in the pharmaceutical industry on account of the advantages such models pose for in drug discovery, from improved clinical translation and predictivity, to patient safety and sustainability. SMi’s 3D Cell Culture Conference will explore advances in the application of 3D […]

WHO recommends two new drugs to treat patients with COVID-19

January 17, 2022todi0

The drug baricitinib (a type of drug known as a Janus kinase (JAK) inhibitor, also used to treat rheumatoid arthritis) is strongly recommended for patients with severe or critical COVID-19 in combination with corticosteroids, says a WHO Guideline Development Group of international experts in The BMJ. Their strong recommendation is based on moderate certainty evidence […]

Research team finds new dual benefit mode of action for a drug candidate to fight COVID-19

January 14, 2022todi0

A research team led by Prof. Stephan Ludwig, a virologist at the Institute of Virology at the University of Münster, has found a new dual attack mode of action while working on the development of a drug candidate against SARS-CoV-2 infections. This could constitute the basis for a broadly effective drug to fight COVID 19. […]